|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|2762155||1150699||2016||3 صفحه PDF||سفارش دهید||دانلود کنید|
• Antiphospholid antibodies increase the perioperative risk in cardiac surgery.
• A minimally invasive procedure reduces trauma and bleeding risk.
• The low bleeding risk allows early start of postoperative anticoagulation.
• Bivalirudin's unique pharmacology provides efficient and safe anticoagulation.
• Adjustment of the surgical strategy and anticoagulation may increase patient safety.
The occurrence of lupus anticoagulant is associated with the hazard of developing an antiphospholipid syndrome, a severe prothrombotic condition which may particularly occur after major surgical trauma. This disease requires certain considerations regarding surgical strategy and anticoagulation management. We describe the perioperative management of a patient scheduled for elective aortic valve replacement and diagnosed for having antiphospholipid antibodies. The procedure was successfully performed using a minimally invasive approach via transapical aortic valve replacement and anticoagulation with the nonreversible short-acting direct thrombin Inhibitor bivalirudin.
Journal: Journal of Clinical Anesthesia - Volume 33, September 2016, Pages 373–375